Danish medical device company TOOsonix has formed a strategic collaboration with Consultronix to introduce its “focused” ultrasound skin therapy in Poland.
This partnership aims to offer healthcare professionals a solution for treating skin conditions.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The dermatological therapy of TOOsonix, System ONE-M, which is Medical Device Regulation (MDR) CE-marked, is intended for age-related skin conditions, inclusive of basal cell carcinoma, seborrheic keratosis, and actinic keratosis.
Treatment with this therapy claims to be quick, eliminating the need for anaesthesia or post-treatment care, with efficacy and aesthetic results against traditional methods.
According to TOOsonix, the collaboration could significantly enhance the quality of care for those suffering from skin conditions.
Consultronix’s network and “expertise” in the Polish healthcare sector are expected to facilitate widespread access to these therapies.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataTOOsonix System ONE-M treatment involves a handpiece that contacts the skin lesion directly and the operator can activate focused ultrasound doses while monitoring the process in real time on the system’s screen.
Consultronix has experience in launching medical technologies in the country. Its connections with dermatology hospitals and clinics are crucial for the deployment of TOOsonix’s products.
Consultronix CEO Piotr Smolarski said: “We are proud to collaborate with TOOsonix. Their groundbreaking dermatological therapies align perfectly with our mission to equip Polish healthcare professionals with the best tools for addressing evolving patient needs.”
The partnership is a significant step in TOOsonix’s strategy to expand its global reach, particularly within Europe.
TOOsonix founders Tomasz Zawada and Torsten Bove said: “We are thrilled to partner with Consultronix to expand our presence in Central Europe.
“Consultronix’s deep understanding of the Polish market and commitment to quality make them an ideal partner. Together, we aim to enhance patient outcomes by offering innovative dermatological solutions.”
